The new Long Stay Antipsychotic Quality Measure

The Long-stay antipsychotic quality measure has been revised. It is essentially a new quality measuring antipsychotic use among the long stay that will rely on MDS and claims data to not only record antipsychotic use but verify excluding diagnose like schizophrenia as well. The 5-star ratings on Care Compare will be updated in January ’26…